scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicVaccine authorisation

Topic: Vaccine authorisation

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

Why you won’t get Covishield, Covaxin at a chemist yet, despite full market approval

Covishield and Covaxin have been fully authorised only for use in adults, and can only be used in a ‘programmatic setting’, which means you’ll still have to register on CoWin.

Novavax’s Covid vaccine, made by Serum Institute of India, gets emergency use nod in Indonesia

Serum Institute of India, world's largest vaccine manufacturer, will market the nanoparticle protein-based vaccine in Indonesia under the brand name Covovax.

On Camera

Indians have a complicated relationship with Zohran Mamdani

Mamdani’s politics feels unusual compared to India’s current climate. He unapologetically foregrounds Muslim identity at a time when doing so in India invites scrutiny.

What does NCLAT order mean for data-sharing ban, penalty imposed by CCI on Meta & WhatsApp

On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.